Literature DB >> 6574163

Tobacco usage in patients with head and neck carcinomas: a follow-up study on habit changes and second primary oral/oropharyngeal cancers.

S Silverman, M Gorsky, D Greenspan.   

Abstract

One hundred and sixty patients with head and neck carcinomas were followed from one to 15 years to assess the associations between tobacco usage and the development of multiple head and neck cancers. Seventy-three percent had tobacco habits, with nine of ten users smoking cigarettes. In almost one in five patients (18.1%), second primary oral/oropharyngeal cancers developed in a mean time of five years. Those who did not change their original tobacco habits incurred the greatest risk, as a second primary cancer developed in 30%. Reducing or discontinuing smoking appeared to have a beneficial effect. There was also an increased risk for multiple cancers in males, probably because of their larger amount of daily smoking.

Entities:  

Mesh:

Year:  1983        PMID: 6574163     DOI: 10.14219/jada.archive.1983.0004

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN: 0002-8177            Impact factor:   3.634


  10 in total

1.  Impact of postdiagnosis smoking on long-term survival of cancer patients: the Shanghai cohort study.

Authors:  Li Tao; Renwei Wang; Yu-Tang Gao; Jian-Min Yuan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12       Impact factor: 4.254

2.  Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers.

Authors:  Samuel J Gan; Kristina R Dahlstrom; Brandon W Peck; Wes Caywood; Guojun Li; Qingyi Wei; Mark E Zafereo; Erich M Sturgis
Journal:  Cancer       Date:  2013-04-19       Impact factor: 6.860

3.  Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer.

Authors:  Jamboor K Vishwanatha; Ryan Swinney; Abhijit G Banerjee
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

4.  Clinical factors related to suspected second primary lung cancer development in patients with head and neck cancer.

Authors:  Eui Bae Kim; Yong Park; Seh Jong Park; Dae Sik Kim; Jee Won Kim; Hee Yun Seo; Hwa Jung Sung; In Keun Choi; Kyong Hwa Park; Sang Cheul Oh; Chul Won Choi; Byung Soo Kim; Yeul Hong Kim; Jun Suk Kim; Sang Won Shin; Chul Yong Kim; Kwang-Yoon Jung
Journal:  Cancer Res Treat       Date:  2008-12-31       Impact factor: 4.679

Review 5.  Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma: role of primary care physicians.

Authors:  Joel B Epstein; Meir Gorsky; Robert J Cabay; Terry Day; Wanda Gonsalves
Journal:  Can Fam Physician       Date:  2008-06       Impact factor: 3.275

6.  Impact of oral and oropharyngeal cancer diagnosis on smoking cessation patients and cohabiting smokers.

Authors:  Jenny L Gray; Adnan Al Maghlouth; Hussain Al Hussain; Mohammed Al Sheef
Journal:  Tob Induc Dis       Date:  2019-11-01       Impact factor: 2.600

7.  Mutagen sensitivity and risk of second cancer in younger adults with head and neck squamous cell cancer: 15-year results.

Authors:  B Bukovszky; J Fodor; G Székely; S Zs Kocsis; F Oberna; T Major; Z Takácsi-Nagy; C Polgár; Z Jurányi
Journal:  Strahlenther Onkol       Date:  2022-03-31       Impact factor: 4.033

Review 8.  Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis.

Authors:  A Parsons; A Daley; R Begh; P Aveyard
Journal:  BMJ       Date:  2010-01-21

9.  Should fluorodeoxyglucose positron emission tomography/computed tomography be the first-line imaging investigation for restaging the laryngeal carcinoma patients?

Authors:  Tarun Kumar Jain; Guman Singh; Sumit Goyal; Ajay Yadav; Dinesh Yadav; Nitin Khunteta; Hemant Malhotra
Journal:  World J Nucl Med       Date:  2021-02-12

10.  Smoking habits among patients diagnosed with oral lichen planus.

Authors:  Meir Gorsky; Joel B Epstein; Haya Hasson-Kanfi; Eliezer Kaufman
Journal:  Tob Induc Dis       Date:  2004-06-15       Impact factor: 2.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.